www.investormeetup.com - Investor Meetup
  1. Home
  2. United States Of America
  3. Companies
  4. Ibere Pharmaceuticals
Claim Listing - Ibere Pharmaceuticals Are you Ibere Pharmaceuticals? Claim this listing now. Claim Listing
Investors Ibere Pharmaceuticals in

Ibere Pharmaceuticals

Companies

Send Chat Message

Company Member Details

Company Name
Ibere Pharmaceuticals
Company Industry
Listing Month
21-Feb
Exchange
NYSE
Ticker Symbol
IBER.U

To view Contact details for this Company member
please subscribe to our Investor Premium Plan. or Buyer Premium Plan.

To view Additional details for this Company member
please subscribe to our Investor Premium Plan. or Buyer Premium Plan.

Ibere Pharmaceuticals Specialties

Companies for Sale
Request Information »
SPAC Company for Sale
Request Information »
Companies for Sale
Request Information »
SPAC Company for Sale
Request Information »

Contact Ibere Pharmaceuticals

Related Searches



Join our Newsletter


Get the latest updates whether you are an investor, company or buyer.


Join our Newsletter


Get the latest updates whether you are an investor, company or buyer.


  • About
    • Companies can raise capital easier by searching our trusted network of top-rated Investors.
  • Website
  • Search
  • Support
  • Become a Member
  • Disclosures: InvestorMeetup.com is a website owned and operated by Investor Meetup (“IMU”), a DBA of Investor Data Strategies LLC. IMU receives payments from companies and investors that establish directory listings and other listings on our website including for securities offerings, companies for sales, interested buyers, and investors. Please be aware that this payment structure could potentially place IMU in a position of conflict of interest with the investor. Kindly refer to the IMU fee schedule. By visiting this website or any of its pages, you agree to comply with the Terms of Use and Privacy Policy, as updated and in effect at the most recent moment of your access. Nothing on this website should be interpreted as an offer to sell or a solicitation of an offer to subscribe for or purchase securities to any person in any jurisdiction where such offer or solicitation is unlawful. Consequently, a featured, front-page, or prominent display of a listed company or client on this site should not be construed as an endorsement and could be based on various algorithms or selections that direct traffic to the mentioned company. IMU is not a registered law firm, valuation service, underwriter, broker-dealer, or Title III crowdfunding portal and does not conduct any activities requiring such registration. IMU does not offer investment advice or structure transactions. Do not substitute any advice from IMU staff for professional guidance. When IMU staff give advice, it is based on their observations of effective and non-effective strategies from a marketing perspective in online offerings. IMU does not instruct the audience on actions or procedures but suggests what could be more straightforward and cost-effective to market online. The final decisions on all elements of company offerings are made by the offering companies. Listed companies on this site are actively seeking to raise early-stage capital under Rule 506(b) or Rule 506(c) of Regulation D ("Regulation D") or Regulation A ("Regulation A") under the U.S. Securities Act of 1933, as amended (the "Securities Act"). The offerings made by a listed company, and all the information regarding the company and its securities, are provided by the company itself. If the offerings are made pursuant to Rule 506(b) or Rule 506(c) of Regulation D, they are generally only available to "accredited investors" as defined by Regulation D. Accredited investors can identify listed companies they may be interested in after a certification process for Rule 506(b) offerings, while Rule 506(c) offerings are available for public viewing. Offerings made under Regulation A are also generally available for public viewing. Investment in securities, especially those issued by start-up companies, carries substantial risk, and investors should be prepared for a complete loss of their investment. All investors should independently evaluate and analyze any investment. See our Investor Education Guide and Associated Risks. IMU does not verify or guarantee the accuracy or completeness of the information supplied by any company listed on the site offering its securities, nor does it affirm the validity of the valuation of such securities. The material (pages, blogs, FAQs, news) shared on IMU may contain inaccuracies, and it's crucial to always seek professional advice. IMU, including its directors, officers, employees, representatives, affiliates, or agents, bears no responsibility or liability for any inaccuracies, errors, or oversight in the assembly of the materials shared on this website. IMU does not offer legal, accounting, or tax consultancy. Any suggestion or implication to the contrary is firmly denied.